Entry
Name
Relaxin signaling pathway - Ailuropoda melanoleuca (giant panda)
Description
Human relaxin-2 ("relaxin"), originally identified as a peptidic hormone of pregnancy, is now known to exert a range of pleiotropic effects including vasodilatory, anti-fibrotic and angiogenic effects in both males and females. It belongs to the so-called relaxin peptide family which includes the insulin-like peptides INSL3 and INSL5, and relaxin-3 (H3) as well as relaxin. INSL3 has clearly defined specialist roles in male and female reproduction, relaxin-3 is primarily a neuropeptide involved in stress and metabolic control, and INSL5 is widely distributed particularly in the gastrointestinal tract. These members of relaxin peptide family exert such effects binding to different kinds of receptors, classified as relaxin family peptide (RXFP) receptors: RXFP1, RXFP2, RXFP3, and RXFP4. These G protein-coupled receptors predominantly bind relaxin, INSL3, relaxin-3, and INSL-5, respectively. RXFP1 activates a wide spectrum of signaling pathways to generate second messengers that include cAMP and nitric oxide, whereas RXFP2 activates a subset of these pathways. Both RXFP3 and RXFP4 inhibit cAMP production, and RXFP3 activate MAP kinases.
Class
Organismal Systems; Endocrine system
BRITE hierarchy
Pathway map
Organism
Ailuropoda melanoleuca (giant panda) [GN:
aml ]
Gene
100463775 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
100465448 CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048 ]
100466130 GNAO1; guanine nucleotide-binding protein G(o) subunit alpha isoform X2 [KO:K04534 ]
100466408 GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630 ]
100467069 SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500 ]
100467255 GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539 ]
100467906 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ]
100467916 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649 ]
100468197 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541 ]
100468916 GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
100469944 GNA15; guanine nucleotide-binding protein subunit alpha-15 isoform X1 [KO:K04637 ]
100470703 TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375 ]
100470867 CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048 ]
100471622 GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544 ]
100471767 GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630 ]
100472104 CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048 ]
100474135 ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X2 [KO:K04450 ]
100474261 CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047 ]
100474779 PLCB2; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858 ] [EC:3.1.4.11 ]
100474825 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536 ]
100475291 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
100475394 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546 ]
100475485 GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 isoform X1 [KO:K07825 ]
100475635 GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548 ]
100476017 ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X2 [KO:K09049 ]
100476214 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547 ]
100476284 ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374 ]
100476550 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549 ]
100476938 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542 ]
100477221 GNG14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347 ]
100477225 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 isoform X1 [KO:K04347 ]
100477711 CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870 ]
100479175 INSL5; LOW QUALITY PROTEIN: insulin-like peptide INSL5 [KO:K22001 ]
100479294 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
100479580 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922 ] [EC:2.7.1.153 ]
100480040 GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538 ]
100480694 SHC2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447 ]
100481755 PLCB1; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858 ] [EC:3.1.4.11 ]
100482029 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826 ]
100482213 VEGFD; vascular endothelial growth factor D isoform X1 [KO:K05449 ]
100483125 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543 ]
100483209 GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540 ]
100483482 CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X1 [KO:K09048 ]
100483828 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
100484531 CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048 ]
100484553 GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537 ]
100484933 GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630 ]
105236417 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545 ]
Compound
C01245 D-myo-Inositol 1,4,5-trisphosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ
Title
Relaxin family peptides and their receptors.
Journal
Reference
Authors
Cernaro V, Lacquaniti A, Lupica R, Buemi A, Trimboli D, Giorgianni G, Bolignano D, Buemi M
Title
Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.
Journal
Reference
Authors
van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ
Title
Relaxin family peptide receptors--from orphans to therapeutic targets.
Journal
Reference
Authors
Halls ML, van der Westhuizen ET, Bathgate RA, Summers RJ
Title
Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Journal
Reference
Authors
Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ
Title
International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Journal
Reference
Authors
Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ
Title
Cardiovascular effects of relaxin: from basic science to clinical therapy.
Journal
Reference
Authors
Nistri S, Bani D
Title
Relaxin receptors and nitric oxide synthases: search for the missing link.
Journal
Reference
Authors
Samuel CS, Hewitson TD, Unemori EN, Tang ML
Title
Drugs of the future: the hormone relaxin.
Journal
Reference
Authors
Sasser JM
Title
The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.
Journal
Reference
Authors
Sarwar M, Du XJ, Dschietzig TB, Summers RJ
Title
The actions of relaxin on the human cardiovascular system.
Journal
Reference
Authors
Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ
Title
Receptors for relaxin family peptides.
Journal
Reference
Authors
Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS
Title
Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
Journal
Reference
Authors
Samuel CS, Du XJ, Bathgate RA, Summers RJ
Title
'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.
Journal
Reference
Authors
Wilson SS, Ayaz SI, Levy PD
Title
Relaxin: a novel agent for the treatment of acute heart failure.
Journal
Reference
Authors
Halls ML, Bathgate RA, Summers RJ
Title
Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
Journal
Reference
Authors
Kocan M, Ang SY, Summers RJ
Title
Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
Journal
Reference
Authors
van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ
Title
The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
Journal
Related pathway
aml04270 Vascular smooth muscle contraction
KO pathway